Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
I suppose from a technical point of view, Afrezza, in its current form, was only rejected by FDA once (as the article states). The first CRL was for Medtone, the second for Dreamboat.
